BioNeutral Group, Inc. Company Profile
Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a specialty technology-based life-science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene® and Ogiene®, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene® brand have been approved by the EPA for sale in the United States and has previously been approved for sale in Germany and it is also permitted to be sold in the UK, France and Sweden. Auto Neutral is a registered trademark of BioNeutral Group, Inc. For more information on BioNeutral, including a listing of company products, leadership and background please visit www.bioneutral.com.
News Articles
BioNeutral Group Expands The Testing Of Its Ygiene Sterilant Against Anthrax Spores
MORRISTOWN, N.J., July 3, 2012 /PRNewswire/ -- BioNeutral Group, Inc. (OTCBB: BONU) a specialty life science technology based company announced today that it has contracted Battelle to test its Ygiene...
BioNeutral Group Appoints Mr. Mark Lowenthal as Chief Executive and President
NEWARK, N.J., July 9, 2012 /PRNewswire/ -- BioNeutral Group, Inc., (OTC Bulletin Board: BONU - News), a specialty life science technology-based company, today announced that M...
MORRISTOWN, N.J., Nov. 28, 2012 /PRNewswire/ -- BioNeutral Group, Inc. (OTCBB: BONU) a specialty life science technology based company announced today that it has received positive test results f...
BioNeutral appoints sales team
MORRISTOWN, N.J., Nov. 29, 2012 /PRNewswire/ -- BioNeutral Group, Inc. (OTCBB: BONU) a specialty life science technology based company is proud to announce today that upon the successful completi...
BioNeutral Enters Into Equity Purchase Agreement With Southridge Partners II
MORRISTOWN, N.J., Dec. 13, 2012 /PRNewswire/ -- BioNeutral Group, Inc. (OTCBB: BONU) a specialty life science technology based company is pleased to announce it has entered into an Equity Purchas...
BioNeutral Gains Initial Market Acceptance
NEWARK, N.J., Feb. 25, 2013 /PRNewswire/ -- Mark Lowenthal, President and CEO of BioNeutral Group, Inc. (OTCBB: BONU), a specialty technology-based life-science company, announced today that foll...
BioNeutral Group Appoints A New Member to the Board of Directors
NEWARK, N.J., June 29, 2012 /PRNewswire/ -- BioNeutral Group Inc. (OTCBB: BONU) a specialty life science technology based company announced today expansion of its Board of Directors. Michael D. F...
MORRISTOWN, N.J., Oct. 2, 2012 /PRNewswire/ -- BioNeutral Group Inc. (OTC Bulletin Board: BONU), a specialty life science technology-based company, and Barnabas Health of West Orange,...
Drugs and Medications
Ethyl alcohol [H and P Industries, Inc. dba Triad Group]
DRUG FACTS
DRUG FACTS
Alba hawaiian coconut siscreen spf 15 [The Hain Celestial Group, Inc.]
Drug Facts
Glycerin [H and P Industries, Inc. dba Triad Group]
DRUG FACTS
Alba sunblock natural facial spf 30 [The Hain Celestial Group, Inc.]
Drug Facts
PubMed Articles
None
Clinical Trials
The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...
Short Term Group Therapy for OCD
Assessing OCD before and after group therapy
Psychological Prevention of Internalizing Disorders
The purpose of this study is to determine whether cognitive-behavioral group prevention (CBT-G) for german children is effective and to what extent parental group training moderates outcom...
The purpose of the study is to verify superiority of the lafutidine group over the placebo group and non-inferiority to the famotidine group in terms of endoscopic healing rate of the pati...
Clinical Trial of Donepezil Between the Naive Group and the Switching Group
To compare the clinical efficacy of donepezil between the naive group and the switching group.
Companies
Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a specialty technology-based life-science company which has developed a technolog...
BioNeutral Laboratories Corporation
BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms incl...
W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital...
PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...
Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...
More Information about "BioNeutral Group, Inc." on BioPortfolio
We have published hundreds of BioNeutral Group, Inc. news stories on BioPortfolio along with dozens of BioNeutral Group, Inc. Clinical Trials and PubMed Articles about BioNeutral Group, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioNeutral Group, Inc. Companies in our database. You can also find out about relevant BioNeutral Group, Inc. Drugs and Medications on this site too.
